The data on the usage of blood and blood-forming organs medicine in the Netherlands demonstrates a gradual and stable increase from 2013 to 2028. In 2023, the usage stood at 143.9 Defined Daily Dosage (DDD) per thousand persons per day. Between 2012 and 2023, year-on-year variations fluctuated, peaking at a 2.61% increase in 2017 and dipping into slight declines in 2019 and 2020.
The average year-on-year variation for the past two years remained positive, showing a consistent uptick in demand. Meanwhile, the Compound Annual Growth Rate (CAGR) over the last five years is minimal at 0.098%, showcasing slower annual growth. The forecast suggests a continued modest increase, with a five-year CAGR only marginally higher at 0.19%, reflecting sustained yet moderate demand growth till 2028.
- The market exhibited minor fluctuations over the years but maintained an overarching upward trend.
- 2023 to 2028 forecasts predict stable growth, emphasizing a continuous need for these medicines.
Future trends to watch for include ongoing medical advancements, potential changes in healthcare policies, and demographic shifts that may impact medication demand. Monitoring these factors will be essential in anticipating any significant deviations from the forecasted steady growth.
